---
permalink: /patents/
title: "Patents"
author_profile: true
redirect_from: 
  - /md/
  - /markdown.html
---

<p style="color:#2C91F5; text-decoration: none; cursor: default !important; font-weight: bold;" >CRISPR-PE System For Retinol Dehydrogenase 12 (Rdh12) Gene Mutations For Use In The Treatment
Of Retinitis Pigmentosa (RP) Disease (TR/EU, pending, No: TR2021022284A2 / WO2023129095A1) </p> 


<p style="color:#2C91F5; text-decoration: none; cursor: default !important; font-weight: bold;" >Exon 13 Skipping Xeno Nucleic Acid Antisense-Oligonucleotide (XNA-ASO) Sequences For Genetic Therapy Of USH2A-Induced Retinitis Pigmentosa (TR/EU, pending, No: TR2022001648A2 / WO2023154026A1)</p> 

<p style="color:#2C91F5; text-decoration: none; cursor: default !important; font-weight: bold;" >Neural Lentiviral Vector Containing The Functional Abca4 Gene For Use In The Treatment Of Retinitis
Pigmentosa (RP) Disease (TR, pending, No: TR2022000448A2)</p> 

<p style="color:#2C91F5; text-decoration: none; cursor: default !important; font-weight: bold;" >Methods for the Treatment of Spinal Muscular Atrop (TR, pending, No: 2021/018884)</p> 

<p style="color:#2C91F5; text-decoration: none; cursor: default !important; font-weight: bold;" >â€¢ Neurotrophic Factor And Optogenetic System-Based Lentiviral System For Use In Retinal Diseases (TR,
pending, No: TR2022021763A2)</p> 
